A
Amylyx Pharmaceuticals (AMLX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Amylyx Pharmaceuticals (AMLX)
Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapies for treatment paradigm for amyotrophic lateral sclerosis (ALS), and range of neurodegenerative diseases by keeping neurons alive. The Comp... Read more
- USD2.05
- USD2.13
- USD2.00
- USD30.50
- -22.80%
- 381M
- 6.78k
- 2.30M
- 138M
- 1.70
- -92.80%
Stock News
4 hours ago
Three Leading Canadian Dividend Stocks With Yields Up To 5.5%
Yahoo
5 hours ago
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
Yahoo
6 hours ago
Deckers Outdoor Corporation (DECK) Continued its Strong Performance in Q1
Yahoo
6 hours ago
Cable One (CABO) Impacted by Challenging Market Environment
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
